An Open Phase I Study to Assess the Biological Effects of a Continuous Intravenous Infusion of Interleukin-3 Followed by Granulocyte Macrophage-Colony Stimulating Factor

Author： Bretti S.   Gilleece M.H.   Kamthan A.   Fitzsimmons L.   Hicks F.   Rowlands M.   Bishop P.   Picardo A.-M.   Dexter T.M.   Scarffe J.H.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.32, Iss.7, 1996-06, pp. : 1171-1178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of irradiated tumor vaccine and infusion of granulocyte-macrophage colony-stimulating factor and interleukin-12 on established gliomas in rats

By Chen Jin-Cherng   Chen Yun   Wu Jiann-Ming   Su Yen-Hao   Tai Kuo-Feng   Tseng Sheng-Hong  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 7, 2006-07 ,pp. : 873-883

Springer Publishing Company

Access to resources Recommend Favorite

The Expression and Action of Granulocyte Macrophage-Colony Stimulating Factor and Its Interaction with TGF- in Endometrial Carcinoma

By Ripley D.   Tang X.-M.   Ma C.   Chegini N.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 301-309

Elsevier

Access to resources Recommend Favorite

Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-hodgkin’s lymphoma

By Sparano Joseph   Negassa Abdissa   Lansigan Erick   Locke Robin   Silva Chamath   Wiernik Peter  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 257-267

Humana Press, Inc

Access to resources Recommend Favorite

Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony-stimulating factor: I. Derivation, genetic stability, oncogenicity and immunogenicity

By      

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1668-1676

Spandidos Publications

Access to resources Recommend Favorite

Phase trial of granulocyte-macrophage colony-stimulating factor plus thalidomide in older patients with castration-resistant prostate cancer

By      

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 865-868

Science Publishers

Access to resources Recommend Favorite